COMPANY DESCRIPTION
WuXi AppTec’s Laboratory Testing Division is a leading contract research organization (CRO) providing comprehensive preclinical testing services to accelerate global drug discovery and development. With GLP-compliant laboratories in the United States and China, we deliver integrated expertise in bioanalytical services, DMPK studies, toxicology, and central laboratory support. Our teams support small molecules, biologics, and advanced modalities such as peptides, oligonucleotides, antibody–drug conjugates (ADCs), PROTACs, CAR-T, and mRNA therapeutics. Leveraging advanced platforms including LC-MS/MS, ELISA, qPCR, and flow cytometry, we generate high-quality, regulatory-ready data. By combining scale, scientific expertise, and project management excellence, WuXi AppTec helps sponsors worldwide reduce risk, meet regulatory milestones, and bring innovative therapies to patients faster.
COMPANY BACKGROUND
Founded to advance healthcare innovation, WuXi AppTec’s Laboratory Testing Division provides end-to-end R&D solutions for the pharmaceutical and biotech industry, building on decades of preclinical expertise with global teams, advanced technology, and regulatory insight, enabling clients to accelerate development from discovery through IND and NDA submission.
MARKETS SERVED/FACILITIES
WuXi AppTec’s Laboratory Testing Division serves global pharmaceutical, biotech, and academic organizations across North America, Europe, and Asia. Our facilities include more than one million square feet of GLP laboratories in the U.S. and China, staffed by 2,500+ scientists specializing in bioanalysis, DMPK, toxicology, and central laboratory services for diverse therapeutic programs.
PRODUCTS, SERVICES & CAPABILITIES
WuXi AppTec’s Laboratory Testing Division delivers a full spectrum of preclinical and clinical research services. Our bioanalytical services include method development, validation, biomarker testing, and central laboratory support. DMPK studies span in vitro and in vivo ADME, drug–drug interaction evaluation, pharmacokinetics, and metabolite ididentificationSafety assessment services include genetic, reproductive, and developmental toxicology, vaccine testing, and pathology. Global central labs in New Jersey and Shanghai provide standardized sample management, logistics, and data reporting. With advanced automation and platforms such as LC-MS/MS, ELISA, qPCR, and flow cytometry, we support small molecules, biologics, and novel modalities. Our integrated solutions ensure compliance with ICH M10 and FDA bioanalytical method validation guidelines, helping clients achieve development milestones efficiently.
